ARCHIVES

Isis 3521 Gets Fast-track Status For FDA Review.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985

Richard Pestell To Lead Lombardi Cancer Cente

September 6, 2002

In Brief: NCI Grants Get More Money, Pay Line Boosted To 193

May 22, 1981

NCI director creates four new deputy director positions to manage the Institute.

February 20, 2004

In Brief: Benacerraf, Snell, Dausset Win Nobel Prize; AACE Seeks Increase In Clinical Education Funds

October 17, 1980

NCI selects nanotech centers for funding.

October 14, 2005